We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.57B
AUM Growth
+$240M
Cap. Flow
-$1.33M
Cap. Flow %
-0.05%
Top 10 Hldgs %
34.11%
Holding
1,211
New
84
Increased
525
Reduced
539
Closed
63

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$18.8M
2
LIN icon
Linde
LIN
+$15.3M
3
AVGO icon
Broadcom
AVGO
+$2.95M
4
AMD icon
Advanced Micro Devices
AMD
+$2.59M
5
HD icon
Home Depot
HD
+$1.46M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$6.03M
2
MSFT icon
Microsoft
MSFT
+$5.38M
3
CVX icon
Chevron
CVX
+$4.36M
4
META icon
Meta Platforms (Facebook)
META
+$4.08M
5
AAPL icon
Apple
AAPL
+$3.64M

Sector Composition

Rank Sector Weight
1 Technology 42.5%
2 Healthcare 12.67%
3 Consumer Discretionary 11.07%
4 Communication Services 9.14%
5 Financials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSK icon
501
GSK
GSK
$104B
$624K 0.02%
14,546
-2,038
-12% -$84K
RGNX icon
502
Regenxbio
RGNX
$622M
$622K 0.02%
29,500
+7,850
+36% +$140K
LII icon
503
Lennox International
LII
$19B
$619K 0.02%
1,267
+228
+22% +$104K
XPEV icon
504
XPeng
XPEV
$12.2B
$619K 0.02%
80,628
+53,258
+195% +$516K
FICO icon
505
Fair Isaac
FICO
$29.7B
$617K 0.02%
494
+8
+2% +$10K
NVR icon
506
NVR
NVR
$16.9B
$616K 0.02%
76
+8
+12% +$59.4K
COR icon
507
Cencora
COR
$60.5B
$615K 0.02%
2,533
-318
-11% -$73.1K
PHM icon
508
Pultegroup
PHM
$24.9B
$615K 0.02%
5,102
+509
+11% +$54.6K
SAIA icon
509
Saia
SAIA
$11.2B
$614K 0.02%
1,049
+189
+22% +$98.9K
P
510
Everpure Inc
P
$24.7B
$611K 0.02%
+11,753
New +$525K
MANH icon
511
Manhattan Associates
MANH
$9.42B
$609K 0.02%
2,434
+436
+22% +$104K
RPRX icon
512
Royalty Pharma
RPRX
$26B
$609K 0.02%
20,047
+1,753
+10% +$51.7K
CX icon
513
Cemex
CX
$17.6B
$606K 0.02%
67,260
-13,623
-17% -$109K
ULTA icon
514
Ulta Beauty
ULTA
$20.7B
$603K 0.02%
1,154
+75
+7% +$38.7K
ELAN icon
515
Elanco Animal Health
ELAN
$12.7B
$603K 0.02%
37,012
-3,818
-9% -$59.7K
APA icon
516
APA Corp
APA
$12.3B
$601K 0.02%
17,484
-1,755
-9% -$55.6K
RLAY icon
517
Relay Therapeutics
RLAY
$4.06B
$600K 0.02%
72,349
+18,320
+34% +$179K
STLD icon
518
Steel Dynamics
STLD
$36.1B
$599K 0.02%
4,043
+54
+1% +$6.79K
HLX icon
519
Helix Energy Solutions
HLX
$1.42B
$598K 0.02%
55,178
+1,907
+4% +$18.6K
CDNA icon
520
CareDx
CDNA
$1.88B
$597K 0.02%
56,383
+25,075
+80% +$251K
CORT icon
521
Corcept Therapeutics
CORT
$9.78B
$594K 0.02%
23,581
+7,427
+46% +$175K
RELX icon
522
RELX
RELX
$62.3B
$589K 0.02%
13,600
-1,907
-12% -$80.6K
OC icon
523
Owens Corning
OC
$11.6B
$586K 0.02%
3,516
+629
+22% +$96K
DECK icon
524
Deckers Outdoor
DECK
$13.6B
$582K 0.02%
3,708
-1,284
-26% -$178K
EQH icon
525
Equitable Holdings
EQH
$13.3B
$580K 0.02%
15,249
-1,091
-7% -$37.1K

Similar funds

Profund Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Profund Advisors held 1,211 positions worth $2.57B, up 10% from $2.33B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors's Q1 2024 filing shows 84 new, 525 increased, 539 reduced and 63 closed positions. Its largest new stake was Altimmune: 134,842 shares worth $1.37M. The largest sale was ExxonMobil, an estimated $6.03M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Profund Advisors's largest Q1 2024 buy was Altimmune: 134,842 shares worth $1.37M.
  • Profund Advisors added most to NVIDIA in Q1 2024, an estimated $18.8M increase.
  • Profund Advisors's biggest Q1 2024 reduction was ExxonMobil, cutting an estimated $6.03M.
  • Profund Advisors fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $2.18M.
  • Profund Advisors's ten largest holdings make up 34% of its $2.57B portfolio in Q1 2024.
  • Profund Advisors opened 84 new positions and closed 63 in Q1 2024.
  • Profund Advisors's portfolio value rose 10% quarter-over-quarter to $2.57B.

Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.